期刊文献+

结肠癌细胞株、癌组织及正常结肠粘膜中P^(16)基因异常甲基化率的差异 被引量:1

The Difference of P^(16) Gene's Aberrant Methylation Rate Between Colon Cancer and Normal Colonic Mucosa
下载PDF
导出
摘要 本文采用Southernblot法鉴定了结肠癌细胞株、癌组织及正常结肠粘膜组织中P16基因的甲基化情况。结果在6株结肠癌细胞株中有5株(833%)P16基因CpG岛呈异常甲基化状态,在18例结肠癌组织中13例(722%)呈异常甲基化状态。与之相对,18例正常结肠粘膜组织中仅5例(278%)表现为异常甲基化,提示在结肠癌中P16基因因异常甲基化而失活,这为结肠癌的基因治疗提供了新策略、新目标。 The methylation rate of P 16 gene in colon cancer cell lines,colonic cancer tissue and normal colonic mucosa were examined by Southern blot method.The data showed that aberrant methylation of 5'CpG island of P 16 gene was observed in 5 of 6(83 3%) colon cancer cell lines,13 of 18(72 2%) colon cancer tissue.In contrast,only 5 of 18(27 8%) normal colonic mucosa showed aberrant methylation of the 5'CpG island of P 16 gene.The results suggest that P 16 gene in colon cancer was inactivated by aberrant methylation.This can provide a new tactics and a new target for colon's gene therapy.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 1999年第2期111-113,共3页 Cancer Research on Prevention and Treatment
关键词 结肠癌 P^16基因 甲基化 基因治疗 colon cancer P 16 gene methylation gene therapy
  • 相关文献

参考文献1

  • 1萨姆布鲁克 等 金冬雁等(译).分子克隆实验指南,第2版[M].北京,1992..

共引文献2

同被引文献19

  • 1Seuano M.A new regulatory motify in cell cycle control causingspecific inhibition If cyclinD/CDK4.Nature 1993 ;366:704
  • 2William H,et al.Role of the p16 tumor suppressor gene in cancer.Journal of Clinical Oncology 1998; 16(3):1197
  • 3Stoot F j,et al.The alternative product from the human CDKN2A locus,p14ARF,participate in a regulatory feedback loop with p53 and MDM2.EMBO J 1998; 17:5001
  • 4lily I,et al.p16INK4a and the control of cellular proliferative life span.Carcinogenesis 1999 ;20(6):921
  • 5Jacobs J J L,et al.The oncogene and polycomh-group gene bmilregulates cell proliferation and senescence through the ink4a locus.Nature 1999; (397):164
  • 6Caims P,et al.Frequency of homozygous deletion at p16/CDKN2 in primary human tumors.Nature Genet 1995; (11):210
  • 7Herbert J,et al.Candidate tumor suppressor genes MTS l(p16INK4a)and MTS2(p15INK4a) display frequent homozygous deletion in primary cells from T-but not B-cell lineage acute lymphocytic leukemias.Blood 1994;4:4038
  • 8Maelandsmo GM,et al.Homozygous deletion frequency and expressionn levels of the CDKN2 gene in human sarcomas-Relatiornship to amplification and mRNA levels of CDK4 and CCNDI.Br J Cancer1995;72:393
  • 9Reed A,et al.High frequency of p16(CDKN2/MTS-1/INK4A)inactivation in head and neck squamous cell carcinoma.Cancer Res 1996; 56:3630
  • 10Maesawa C,et al.Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is assoctated with advanced stage esophageal squamous cell carcinoma.Cancer Res 1996;56:3875

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部